# Characterization of Microbial, Immune and Epigenetic Biomarkers for Major Depressive Disorder and ECT Treatment

> **NCT03703414** · — · UNKNOWN · sponsor: **Ziv Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DIAGNOSTIC_TEST:** Fecal microbiota composition analysis and blood cytokine level analysis

## Key facts

- **NCT ID:** NCT03703414
- **Lead sponsor:** Ziv Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-11-01
- **Primary completion:** 2019-10-31
- **Final completion:** 2019-10-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2018-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03703414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03703414, "Characterization of Microbial, Immune and Epigenetic Biomarkers for Major Depressive Disorder and ECT Treatment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03703414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*